4//SEC Filing
TARNOW MICHAEL M 4
Accession 0001209191-20-035608
CIK 0001582313other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:17 PM ET
Size
7.1 KB
Accession
0001209191-20-035608
Insider Transaction Report
Form 4
TARNOW MICHAEL M
Director
Transactions
- Exercise/Conversion
Common Shares
2020-06-09$3.52/sh+5,144$18,107→ 69,713 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-09−5,144→ 0 totalExercise: $3.52Exp: 2020-07-01→ Common Shares (5,144 underlying)
Footnotes (2)
- [F1]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]The shares subject to the option fully vested on June 30, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001263647
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:17 PM ET
- Size
- 7.1 KB